September 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 10.42 billion in 2026 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
January 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.10 billion in 2025 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
January 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
September 2026
The global home diagnostics market size accounted for USD 7.28 billion in 2026 and is expected to reach USD 11.54 billion by 2035, growing at a CAGR of 5.26%.
September 2026
The breast cancer diagnostics market size is valued at USD 21.78 billion in 2026 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
September 2026
The molecular diagnostics market size is calculated at USD 46.61 billion in 2026 and is expected to hit around USD 66.34 billion by 2035 with a CAGR of 3.93%.
September 2026
The global tuberculosis diagnostics market size is calculated at USD 2.70 billion in 2026 and is projected to hit around USD 4.08 billion by 2034 with a CAGR of 5.30%.
September 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 4.35 billion in 2026 with a CAGR of 15.48%.
September 2026
The epigenetics diagnostics market size was evaluated at USD 22.40 billion in 2026 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
September 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17 million in 2026, with a CAGR of 5.09%.
September 2026
The global HIV diagnostics market size was evaluated at USD 1.41 billion in 2026 and is predicted to hit around USD 2.24 billion by 2035, growing at a CAGR of 5.26%.
September 2026
The global transplant diagnostics market size is expected to increase from USD 5.22 billion in 2026 to hit around USD 9.24 billion by 2035, growing at a CAGR of 6.55%.
September 2026
The global point-of-care diagnostics market size is exhibited at USD 65.94 billion in 2026 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
September 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 10.34 billion in 2026 , with a CAGR of 6.36%.
September 2026
The global cardiac AI monitoring and diagnostics market size was evaluated at USD 5.17 billion in 2026 and is predicted to hit around USD 18.89 billion by 2035, growing at a CAGR of 15.48%.
September 2026
The artificial intelligence in diagnostics market size was calculated at USD 2.33 billion in 2026 and is projected to hit around USD 11.82 billion by 2035 with a CAGR of 19.81%.
September 2026
The global in vitro diagnostics (IVD) market size accounted for USD 106.16 billion in 2026 and is expected to reach USD 135.76 billion by 2035.
September 2026
The global cancer diagnostics market size was exhibited at USD 184.96 billion in 2026 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
September 2026
The lyme disease diagnostic devices market size accounted for USD 2.97 billion in 2026 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
September 2026
The global paper diagnostics market size is expected to increase from USD 19.65 billion in 2026 and is expected to attain around USD 31.80 billion by 2034 with a CAGR of 6.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com